The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores
- 21 January 2004
- journal article
- Published by Elsevier
- Vol. 15 (2) , 269-278
- https://doi.org/10.1016/j.nbd.2003.11.002
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Atypical dementia associated with a novel presenilin‐2 mutationAnnals of Neurology, 2003
- Presenilin-1 and Presenilin-2 Exhibit Distinct yet Overlapping γ-Secretase ActivitiesJournal of Biological Chemistry, 2003
- The Arctic mutation interferes with processing of the amyloid precursor proteinNeuroReport, 2002
- Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer’s disease1,2Free Radical Biology & Medicine, 2002
- A Presenilin 1 Mutation Associated with Familial Frontotemporal Dementia Inhibits γ-Secretase Cleavage of APP and NotchNeurobiology of Disease, 2002
- High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different GenesAmerican Journal of Human Genetics, 2000
- Abnormalities in Alzheimer’s Disease Fibroblasts Bearing the APP670/671 MutationNeurobiology of Aging, 1997
- Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimerʼs disease cases with PS1 and APP mutationsNeuroReport, 1997
- Calcium responses in human fibroblasts: A diagnostic molecular profile for Alzheimer's diseaseNeurobiology of Aging, 1996
- Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calciumNeurobiology of Aging, 1988